Gustave Roussy, Cancer Campus, Grand Paris

22 results found.

Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Clinical Trial using Blood test

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Identification of Early Markers of Response and Resistance to Trastuzumab in Patients With Localized Human Epidermal Growth Factor Receptor-2(HER-2)-Positive Breast Cancer Candidates for Breast Conserving Surgery.
Blood test

Fibrosis Clinical Trial using Pravastatin

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Curative Efficacy of Pravastatine in Patients Presented Delayed Cutaneous and Subcutaneous Radio-induced Fibrosis.
Pravastatin

Breast Cancer Clinical Trial using beauty care

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer.
beauty care

Solid Tumors and Non-Hodgkin's Lymphoma Clinical Trial using LY2780301; Gemcitabine

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- A Phase Ib, Open-label, Dose Escalation Study of the Safety, Tolerability and Efficacy of LY2780301 (a p70/AKT Inhibitor) in Combination With Gemcitabine in Patients With Advanced or Metastatic Cancer.
LY2780301; Gemcitabine

Non Small Cell Lung Cancer Clinical Trial using Gefitinib; Tremelimumab

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Phase I, Open-label, Safety, Tolerability and Preliminary Efficacy Study of Tremelimumab in Combination With Gefitinib in EGFR Mutant NSCLC Patients.
Gefitinib; Tremelimumab

Metastatic Castration-resistant Prostate Cancer Clinical Trial using Taxotere; Jevtana

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- A Study of Patient Preference Between Cabazitaxel and Docetaxel in First-line Chemotherapy for Metastatic Castrate-resistant Prostate Cancer.
Taxotere; Jevtana

Neuroblastoma, Brain Tumors, or Solid Tumors Clinical Trial using Temozolomide/Hycamtin (Topotecan)

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 6 Months to 20 years.
- Phase 2 Single- Arm Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Neuroblastoma and Other Paediatric Solid Tumours.
Temozolomide/Hycamtin (Topotecan)

B-cell Non Hodgkin Lymphoma, or Mature B-cell Leukemia Burkitt-ty Clinical Trial using Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C; Rituximab, Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 6 Months to 17 years.
- Intergroup Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Evaluation of Rituximab Efficacy and Safety in High Risk Patients - Phase III Trial.
Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C; Rituximab, Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C

Patients With Gastric Peritoneal Carcinomatosis Clinical Trial using Catumaxomab 100æg; Catumaxomab 140æg

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab. A Randomized Phase II Trial..
Catumaxomab 100æg; Catumaxomab 140æg

Seminoma Clinical Trial using Carboplatin; Etoposide; Cisplatin

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Therapeutic Strategy Guided by PET-TDM for Patients With Grade I or Metastatic Seminoma.
Carboplatin; Etoposide; Cisplatin

Uterine Sarcoma Clinical Trial using doxorubicin, ifosfamide, cisplatin

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years to 65 years.
- Phase III Study About the Effects of the Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas.
doxorubicin, ifosfamide, cisplatin

Medulloblastoma, Brain Tumors, or Neuroectodermal Tumors, Primiti Clinical Trial using Etoposide, carboplatin, melphalan, cisplatin, thiotepa

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting N/A to 10 years.
- Treatment Protocol for High-Risk PNET Brain Tumors in Children With Surgery, Sequential Chemotherapy, Conventional and High-Dose With Peripheral Blood Stem Cell Transplantation and Radiation Therapy.
Etoposide, carboplatin, melphalan, cisplatin, thiotepa

Cancer of the Head and Neck, or Carcinoma, Adenoid Cystic Clinical Trial using Imatinib

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Phase II Study of Imatinib (Glivec) Administered as a Daily Oral Treatment in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck Overexpressing KIT.
Imatinib

Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL) Clinical Trial using Sunitinib; Placebo

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL).
Sunitinib; Placebo

Colorectal Carcinoma Clinical Trial using axitinib

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Assessment of the Tumor Vascular Effects of the Pan-vegfr Tyrosine Kinase Inhibitor Axitinib Using Dynamic Contrast-enhanced Ultrasonography (Dce-us) in Patients With Refractory Metastatic Colorectal Cancer.
axitinib

Metastatic Castration Resistant Prostate Cancer Patients Clinical Trial using metastasis biopsy

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program.
metastasis biopsy

High-risk Medulloblastoma Clinical Trial using Carboplatin + etoposide; Thiotepa; Cyclophosphamide + Busilvex

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting N/A to 5 years.
- Phase I / II Study of Sequential High-dose Chemotherapy With Stem Cell Support in Children Younger Than 5 Years of Age With High-risk Medulloblastoma.
Carboplatin + etoposide; Thiotepa; Cyclophosphamide + Busilvex

Sarcoma of Pelvis Clinical Trial using Tasonermine (TNFa); Melphalan

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 16 years or older.
- Isolated Pelvic and Limb Perfusion With 1mg TNFa in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle.
Tasonermine (TNFa); Melphalan

Epithelial Ovarian Carcinoma, or Figo Stage IIIC Clinical Trial using hyper thermic chemo + surgery

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years to 65 years.
- Phase II Study of Intra-Peritoneal Hyper-Thermic Chemotherapy as Consolidation Therapy for Advanced Epithelial Ovarian Carcinoma.
hyper thermic chemo + surgery

Carcinomas Clinical Trial using Escitalopram

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years to 75 years.
- .
Escitalopram

Non-small Cell Lung Cancer Clinical Trial using clinical observation; adjuvant therapy; 3-dimensional conformal radiation therapy

Gustave Roussy, Cancer Campus, Grand Paris - Recruiting 18 years or older.
- Phase III Study Comparing Post-Operative Conformal Radiotherapy to No Post-Operative Radiotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer and Mediastinal N2 Involvement [Lung ART].
clinical observation; adjuvant therapy; 3-dimensional conformal radiation therapy